CN113142437A - 一种唾液酸复合果蔬汁饮品及其制备方法 - Google Patents
一种唾液酸复合果蔬汁饮品及其制备方法 Download PDFInfo
- Publication number
- CN113142437A CN113142437A CN202110571475.6A CN202110571475A CN113142437A CN 113142437 A CN113142437 A CN 113142437A CN 202110571475 A CN202110571475 A CN 202110571475A CN 113142437 A CN113142437 A CN 113142437A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- sialic acid
- dispersion liquid
- vegetable juice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 title claims abstract description 41
- 235000011389 fruit/vegetable juice Nutrition 0.000 title claims abstract description 40
- 235000012055 fruits and vegetables Nutrition 0.000 title claims abstract description 26
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 239000002131 composite material Substances 0.000 title description 3
- 239000000843 powder Substances 0.000 claims abstract description 78
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 44
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 36
- 102000008186 Collagen Human genes 0.000 claims abstract description 31
- 108010035532 Collagen Proteins 0.000 claims abstract description 31
- 229920001436 collagen Polymers 0.000 claims abstract description 31
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000008213 purified water Substances 0.000 claims abstract description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- -1 sialic acid compound Chemical class 0.000 claims abstract description 22
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 20
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 15
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 15
- 241000251468 Actinopterygii Species 0.000 claims abstract description 14
- 241000168517 Haematococcus lacustris Species 0.000 claims abstract description 14
- 229940041514 candida albicans extract Drugs 0.000 claims abstract description 14
- 235000019688 fish Nutrition 0.000 claims abstract description 14
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 14
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 14
- 239000012138 yeast extract Substances 0.000 claims abstract description 14
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 13
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 claims abstract description 13
- 241000972773 Aulopiformes Species 0.000 claims abstract description 13
- 235000005976 Citrus sinensis Nutrition 0.000 claims abstract description 13
- 240000002319 Citrus sinensis Species 0.000 claims abstract description 13
- 102000016942 Elastin Human genes 0.000 claims abstract description 13
- 108010014258 Elastin Proteins 0.000 claims abstract description 13
- 240000003394 Malpighia glabra Species 0.000 claims abstract description 13
- 235000014837 Malpighia glabra Nutrition 0.000 claims abstract description 13
- 240000007817 Olea europaea Species 0.000 claims abstract description 13
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 13
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 13
- 235000014443 Pyrus communis Nutrition 0.000 claims abstract description 13
- 229920002549 elastin Polymers 0.000 claims abstract description 13
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 13
- 235000002532 grape seed extract Nutrition 0.000 claims abstract description 13
- 229940087603 grape seed extract Drugs 0.000 claims abstract description 13
- 235000019515 salmon Nutrition 0.000 claims abstract description 13
- 239000001717 vitis vinifera seed extract Substances 0.000 claims abstract description 13
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims abstract description 11
- 235000021560 apple concentrated juice Nutrition 0.000 claims abstract description 11
- 239000004302 potassium sorbate Substances 0.000 claims abstract description 11
- 229940069338 potassium sorbate Drugs 0.000 claims abstract description 11
- 235000010241 potassium sorbate Nutrition 0.000 claims abstract description 11
- 241000167854 Bourreria succulenta Species 0.000 claims abstract description 10
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 10
- 235000019693 cherries Nutrition 0.000 claims abstract description 10
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 10
- 239000011718 vitamin C Substances 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 241000962514 Alosa chrysochloris Species 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims abstract description 5
- 239000006185 dispersion Substances 0.000 claims description 32
- 239000007788 liquid Substances 0.000 claims description 32
- 238000010008 shearing Methods 0.000 claims description 20
- 230000001804 emulsifying effect Effects 0.000 claims description 13
- 238000004945 emulsification Methods 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 7
- 241000269851 Sarda sarda Species 0.000 claims description 6
- 102000000503 Collagen Type II Human genes 0.000 claims description 4
- 108010041390 Collagen Type II Proteins 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 11
- 230000002087 whitening effect Effects 0.000 abstract description 9
- 235000013361 beverage Nutrition 0.000 abstract description 8
- 235000013399 edible fruits Nutrition 0.000 abstract description 8
- 235000016709 nutrition Nutrition 0.000 abstract description 7
- 230000035764 nutrition Effects 0.000 abstract description 6
- 230000003712 anti-aging effect Effects 0.000 abstract description 5
- 235000014058 juice drink Nutrition 0.000 abstract description 2
- 229960005188 collagen Drugs 0.000 abstract 1
- 230000032683 aging Effects 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 235000013793 astaxanthin Nutrition 0.000 description 5
- 239000001168 astaxanthin Substances 0.000 description 5
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 5
- 229940022405 astaxanthin Drugs 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000003925 brain function Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000001050 lubricating effect Effects 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000000663 muscle cell Anatomy 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000000225 synapse Anatomy 0.000 description 2
- 230000005062 synaptic transmission Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000002197 Ehlers-Danlos syndrome Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 241000269819 Katsuwonus pelamis Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000294180 Osmunda japonica Species 0.000 description 1
- 108010053210 Phycocyanin Proteins 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 description 1
- 102000007365 Sialoglycoproteins Human genes 0.000 description 1
- 108010032838 Sialoglycoproteins Proteins 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000003293 cardioprotective effect Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- VEVRNHHLCPGNDU-MUGJNUQGSA-O desmosine Chemical compound OC(=O)[C@@H](N)CCCC[N+]1=CC(CC[C@H](N)C(O)=O)=C(CCC[C@H](N)C(O)=O)C(CC[C@H](N)C(O)=O)=C1 VEVRNHHLCPGNDU-MUGJNUQGSA-O 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 150000002270 gangliosides Chemical class 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- RGXCTRIQQODGIZ-UHFFFAOYSA-O isodesmosine Chemical compound OC(=O)C(N)CCCC[N+]1=CC(CCC(N)C(O)=O)=CC(CCC(N)C(O)=O)=C1CCCC(N)C(O)=O RGXCTRIQQODGIZ-UHFFFAOYSA-O 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000002182 synaptic membrane Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 230000007371 visceral function Effects 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明具体涉及一种唾液酸复合果蔬汁饮品及其制备方法,属于饮料技术领域,所要解决的技术问题是提供一种具有美白、抗老化功效的唾液酸复合果蔬汁饮品,采用的技术方案为:包括以下原料:纯净水、海洋鱼低聚肽粉、苹果浓缩汁、梨浓缩汁、低聚果糖、葡萄籽提取物、胶原蛋白肽、鲣鱼弹性蛋白肽、水解二型胶原蛋白肽粉、唾液酸、酵母抽提物、γ‑氨基丁酸,雨生红球藻、血橙果粉、橄榄果粉、针叶樱桃果粉、鲑鱼蛋白粉、柠檬酸、维生素C、食用香精、山梨酸钾;以及唾液酸复合果蔬汁饮品的制备方法;本发明通过修复细胞活力,唤醒自身自愈能力,达到美白、抗老化的功效,且营养全面,方便食用。
Description
技术领域
本发明属于饮料技术领域,具体涉及一种唾液酸复合果蔬汁饮品及其制备方法。
背景技术
随着社会的不断发展,人们生活水平的逐渐提高,消费者的观念在渐渐的向营养化、保健化、方便化的方向转变和发展。女性更加注重美白抗晒老的保养,随着人们年龄的增长,人体机能逐渐下降,对于营养物质的吸收和合成能力逐渐下降,导致人体皮肤更新能力变差,简单通过食物抗衰老其效果微乎其微,而且由于很多人饮食结构单一,食物中并不能提供人体所需的全部营养,更不能达到美白抗衰老的效果,人体的衰老是细胞的衰老,单一化的美白产品只是治标不治本,效果不理想。饮料是人们日常生活中喜爱的饮品之一,但是目前的饮料多以口感、味道吸引着大量的消费者,如果开发复合果蔬汁饮品,即在口感方面吸引消费者,又具有美白抗衰老的功效,具有重要意义。
发明内容
本发明克服了现有技术存在的不足,提供了一种唾液酸复合果蔬汁饮品及其制备方法,通过提升人体本能,修复细胞活力,唤醒自身自愈能力,从而对达到对人体美白、抗老化的功效,且营养全面,方便食用。
为了解决上述技术问题,本发明采用的技术方案为:一种唾液酸复合果蔬汁饮品,包括以下重量份的原料:
纯净水500~700份、海洋鱼低聚肽粉5~8份、苹果浓缩汁15~25份、梨浓缩汁20~40份、低聚果糖10~16份、葡萄籽提取物0.2~0.6份、胶原蛋白肽6~9份、鲣鱼弹性蛋白肽3~6份、水解二型胶原蛋白肽粉2~8份、唾液酸6~12份、酵母抽提物6~8份、γ-氨基丁酸8~13份,雨生红球藻10~16份、血橙果粉7~12份、橄榄果粉3~6份、针叶樱桃果粉3~6份、鲑鱼蛋白粉2~5份、柠檬酸0.08~0.14份、维生素C3~8份、食用香精0.05~0.1份、山梨酸钾0.05~0.1份。
一种唾液酸复合果蔬汁饮品的制备方法,具体包括以下步骤:
(1)、将海洋鱼低聚肽粉、胶原蛋白肽、鲣鱼弹性蛋白肽、水解二型胶原蛋白肽粉和酵母抽提物混合均匀;
(2)、然后将低聚果糖、唾液酸加入第一份纯净水中溶解,搅拌均匀;
(3)、将步骤(1)中的混合物加入步骤(2)的溶液中,剪切乳化,均质,得到第一份分散液;
(4)、将γ-氨基丁酸、雨生红球藻、鲑鱼蛋白粉和维生素C加入到第二份纯净水中,剪切乳化,均质,得到第二份分散液;
(5)、将苹果浓缩汁、梨浓缩汁、葡萄籽提取物、血橙果粉、橄榄果粉、针叶樱桃果粉和食用香精加入到第三份纯净水,均质,得到第三份分散液;
(6)、将上述第一份分散液、第二份分散液和第三份分散液混合,剪切乳化,均质;
(7)、然后加入柠檬酸、食用香精和山梨酸钾,继续剪切乳化,均质即得唾液酸复合果蔬汁饮品。
第一份分散液剪切乳化时温度维持在45℃~48℃之间;
第二份分散液剪切乳化时温度维持在38℃~40℃之间;
第三份分散液剪切乳化时温度维持在38℃~40℃之间;
第一份纯净水、第二份纯净水和第三份纯净水质量比为:1:1:1。
冷却至室温后将上述第一份分散液、第二份分散液和第三份分散液混合,剪切乳化,均质。
低聚果糖优选纯度为80%以上。
本发明唾液酸复合果蔬汁饮品的规格为:500mL每瓶。开盖后直接饮用。
本发明各原料性质和功能介绍如下:
海洋鱼低聚肽粉:是海洋鱼胶原蛋白的深加工产品,在营养和应用方面有其独特的优势,它们绝大部分是由2-6个氨基酸组成的、分子量集中在200-1000道尔顿的小分子混合肽类,能够被小肠、人体皮肤等直接吸收,具有强大的营养特性,应用性广泛;能够有效解决皮肤及肌肉水分减少问题,适时补充胶原肽,能使皮肤保持年轻;使钙质与骨细胞紧密结合,不会流失或退化;能使眼角膜保持湿润透明,增加眼睛透明度;促使肌肉细胞紧密连结,使其具有弹性及光泽;调节内分泌、保护及强化内脏功能;结合免疫球蛋白,增加免疫力。
苹果浓缩汁、梨浓缩汁为植物汁。
低聚果糖:低聚果糖是一种天然活性物质,它可以明显改善肠道内微生物种群比例,抑制外源致病菌和肠内固有腐败细菌的生长繁殖,调节肠道内平衡,降低血清中胆固醇和甘油三酯的含量,防止便秘和腹泻,使胃肠功能得以改善,新陈代谢趋于正常。
葡萄籽提取物:富含花青素与原花青素,为高效的天然抗氧化剂,能够促进血液循环、加快胆固醇的分解和排除,具有心脏保护作用。
胶原蛋白肽:是胶原的水解产物,胶原蛋白肽是小分子的胶原蛋白。胶原蛋白是不能被人体直接吸收的,水解成胶原蛋白肽则可以被人体主动吸收,可以被身体组织充分吸收。经常食用胶原蛋白肽可以稳定体内钙质,强健骨骼,还能使皮肤更有弹性,延缓衰老、提高机体免疫力、改善睡眠状态等。
鲣鱼弹性蛋白肽:提取自南太平洋深海鲣鱼的心脏动脉球组织,保留了弹性蛋白的标志性氨基酸——锁链素和异锁链素,这两种氨基酸是让皮肤保持弹性和健康的关键。
水解二型胶原蛋白肽粉:富含人体代谢所必需的多肽等生物活性物质,尤其富含软骨、皮肤及毛发代谢所必需的羟脯氨酸,是结缔组织的主要物质基础,健美皮肤,让皮肤水嫩光滑、紧实有弹性。
唾液酸:唾液酸中含有的粘蛋白,具有润滑特性,这种润滑功能与其中唾液酸含量有关,是润滑口腔的主要因素。唾液酸作为神经细胞突触膜上的神经节苷脂和唾液酸糖蛋白的重要结构组成成分,对突触形成和神经传导起着重要的作用,并参与记忆与学习功能。
酵母抽提物:营养丰富、加工性能良好,在一些食品加工中往往能起到有效增强产品鲜美味、醇厚感,同时缓和产品咸味、酸味,掩盖异味等作用,酵母抽提物在很多食品加工业中都得到了较好的应用。可以增强鲜美味,丰富滋味,使口感更醇厚掩盖发酵产生的不良气味和味道,稳定香味。
γ-氨基丁酸:是哺乳动物中枢神经系统主要的抑制性神经递质,具有神经传递、改善脑机能、增强记忆、抗焦虑、治疗癫痫、控制哮喘、调节激素分泌、防止肥胖、促进生殖、活化肝肾、改善神经细胞性老年痴呆、缓解脑血栓、缓解脑动脉硬化造成的头疼、减轻耳鸣等生理功能,广泛应用于食品、医药、化妆品和饲料等。
雨生红球藻:继螺旋藻、小球藻之后发现的一种富含营养价值和药用价值的薇藻。雨生红球藻中含有大量藻蓝蛋白、β-胡萝卜素,其中虾青素的含量占细胞干重的1.5%~3.0%,被看作是天然虾青素的“浓缩品”。由于天然虾青素具有超强的抗氧化活性,其抗氧化能力是维生素E的550~1000倍,被称为“超级维生素E”,同时还具有抗炎功能,被誉为“没有副作用的激素”。
血橙果粉:抗紫外线辅剂。
橄榄果粉:抗氧化辅剂。
针叶樱桃果粉:富含维生素C,能够防感冒,防坏血病,改善人体抵抗能力,促进皮肤胶原蛋白合成,保持肌肤弹性,淡化皱纹。
鲑鱼蛋白粉:含有丰富的不饱和脂肪酸,能有效降低血脂和血胆固醇,有增强脑功能、防治老年痴呆和预防视力减退的功效。
柠檬酸:酸度调节剂。
本发明与现有技术相比具有以下有益效果。
一、本发明中海洋鱼低聚肽粉、胶原蛋白肽、低聚果糖、水解二型胶原蛋白肽粉具有调节内分泌、改善肠道功能、加快新陈代谢、提高机体免疫力的功效,从机体代谢功能上进行调节,唾液酸、γ-氨基丁酸、鲑鱼蛋白粉对突触形成、神经传递、增强脑功能起着重要的作用,对机体神经细胞功能进行调节,苹果浓缩汁、梨浓缩汁用于对人体进一步补充营养,葡萄籽提取物、雨生红球藻、橄榄果粉、血橙果粉、针叶樱桃果粉具有抗氧化剂、抗紫外线的功效,进一步达到美白的功效,酵母抽提物对饮料的口感进行调节,本发明各组分协同配合,各组分的活性成分相互协调,相互辅助,稳定存在,通过修复细胞活力,唤醒自身自愈能力,进而改善因本能下降所引起的各种问题,从根本上来恢复身体的本能,能够消除体内自由基,全面延缓衰老、达到美白的功效。
二、本发明通过简单的工艺形成稳定的乳化体系,最大限度的保留了各种营养元素的能量,易吸收消化,良好的口感,长期饮用可唤醒身体深层的能量,从而增强体质。
具体实施方式
以下结合具体实施例对本发明作进一步说明。
实施例1
一种唾液酸复合果蔬汁饮品的制备方法,包括以下重量份的原料:
纯净水650份、海洋鱼低聚肽粉5.12份、苹果浓缩汁15.13份、梨浓缩汁20.36份、低聚果糖10.53份、葡萄籽提取物0.21份、胶原蛋白肽7.21份、鲣鱼弹性蛋白肽5.61份、水解二型胶原蛋白肽粉7.26份、唾液酸10.23份、酵母抽提物6.02份、γ-氨基丁酸10.66份,雨生红球藻15.96份、血橙果粉8.35份、橄榄果粉3.15份、针叶樱桃果粉5.79份、鲑鱼蛋白粉3.11份、柠檬酸0.08份、维生素C6.52份、食用香精0.05份、山梨酸钾0.05份。
实施例2
一种唾液酸复合果蔬汁饮品的制备方法,包括以下重量份的原料:
纯净水500份、海洋鱼低聚肽粉7.98份、苹果浓缩汁23.77份、梨浓缩汁35.72份、低聚果糖13.63份、葡萄籽提取物0.56份、胶原蛋白肽6.01份、鲣鱼弹性蛋白肽3.50份、水解二型胶原蛋白肽粉2.21份、唾液酸6.04份、酵母抽提物8.01份、γ-氨基丁酸8.05份,雨生红球藻10.12份、血橙果粉7.03份、橄榄果粉5.96份、针叶樱桃果粉6.00份、鲑鱼蛋白粉2.03份、柠檬酸0.10份、维生素C7.98份、食用香精0.06份、山梨酸钾0.06份。
实施例3
一种唾液酸复合果蔬汁饮品的制备方法,包括以下重量份的原料:
纯净水540份、海洋鱼低聚肽粉6.13份、苹果浓缩汁18.94份、梨浓缩汁40.12份、低聚果糖14.21份、葡萄籽提取物0.60份、胶原蛋白肽8.56份、鲣鱼弹性蛋白肽5.96份、水解二型胶原蛋白肽粉8.96份、唾液酸11.96份、酵母抽提物7.22份、γ-氨基丁酸12.00份,雨生红球藻13.55份、血橙果粉12.00份、橄榄果粉5.04份、针叶樱桃果粉3.06份、鲑鱼蛋白粉5.01份、柠檬酸0.13份、维生素C3.21份、食用香精0.08份、山梨酸钾0.08份。
实施例4
一种唾液酸复合果蔬汁饮品的制备方法,包括以下重量份的原料:
纯净水700份、海洋鱼低聚肽粉7.56份、苹果浓缩汁22.45份、梨浓缩汁23.59份、低聚果糖12.65份、葡萄籽提取物0.35份、胶原蛋白肽6.65份、鲣鱼弹性蛋白肽4.21份、水解二型胶原蛋白肽粉5.46份、唾液酸8.72份、酵母抽提物6.35份、γ-氨基丁酸12.99份,雨生红球藻14.36份、血橙果粉10.26份、橄榄果粉4.32份、针叶樱桃果粉4.65份、鲑鱼蛋白粉4.36份、柠檬酸0.14份、维生素C3.02份、食用香精0.09份、山梨酸钾0.09份。
实施例5
一种唾液酸复合果蔬汁饮品的制备方法,包括以下重量份的原料:
纯净水680份、海洋鱼低聚肽粉5.80份、苹果浓缩汁25.02份、梨浓缩汁30.56份、低聚果糖15.98份、葡萄籽提取物0.46份、胶原蛋白肽9.01份、鲣鱼弹性蛋白肽3.06份、水解二型胶原蛋白肽粉3.22份、唾液酸7.36份、酵母抽提物7.35份、γ-氨基丁酸11.56份,雨生红球藻11.25份、血橙果粉11.35份、橄榄果粉3.99份、针叶樱桃果粉3.95份、鲑鱼蛋白粉2.69份、柠檬酸0.09份、维生素C5.81份、食用香精0.10份、山梨酸钾0.10份。
上述实施例1至实施例5的唾液酸复合果蔬汁饮品均通过以下步骤的制备:
(1)、将海洋鱼低聚肽粉、胶原蛋白肽、鲣鱼弹性蛋白肽、水解二型胶原蛋白肽粉和酵母抽提物混合均匀;
(2)、然后将低聚果糖、唾液酸加入第一份纯净水中溶解,搅拌均匀;
(3)、将步骤(1)中的混合物加入步骤(2)的溶液中,剪切乳化,均质,得到第一份分散液;
(4)、将γ-氨基丁酸、雨生红球藻、鲑鱼蛋白粉和维生素C加入到第二份纯净水中,剪切乳化,均质,得到第二份分散液;
(5)、将苹果浓缩汁、梨浓缩汁、葡萄籽提取物、血橙果粉、橄榄果粉、针叶樱桃果粉和食用香精加入到第三份纯净水,均质,得到第三份分散液;
(6)、将上述第一份分散液、第二份分散液和第三份分散液混合,剪切乳化,均质;
(7)、然后加入柠檬酸、食用香精和山梨酸钾,继续剪切乳化,均质即得唾液酸复合果蔬汁饮品。
第一份分散液剪切乳化时温度维持在45℃~48℃之间;
第二份分散液剪切乳化时温度维持在38℃~40℃之间;
第三份分散液剪切乳化时温度维持在38℃~40℃之间;
第一份纯净水、第二份纯净水和第三份纯净水质量比为:1:1:1。
本品营养成分表如下:
项目 | 每100mL(12g) | 营养素参考值 |
能量/kJ | 366 | 4% |
蛋白质/g | 9.5 | 16% |
脂肪/g | 0 | 0% |
碳水化合物/g | 12 | 4% |
钠/mg | 10 | 1% |
上述实施方式仅示例性说明本发明的原理及其效果,而非用于限制本发明。对于熟悉此技术的人皆可在不违背本发明的精神及范畴下,对上述实施例进行修饰或改进。因此,凡举所述技术领域中具有通常知识者在未脱离本发明所揭示的精神与技术思想下所完成的一切等效修饰或改变,仍应由本发明的权利要求所涵盖。
Claims (6)
1.一种唾液酸复合果蔬汁饮品的制备方法,其特征在于,包括以下重量份的原料:
纯净水500~700份、海洋鱼低聚肽粉5~8份、苹果浓缩汁15~25份、梨浓缩汁20~40份、低聚果糖10~16份、葡萄籽提取物0.2~0.6份、胶原蛋白肽6~9份、鲣鱼弹性蛋白肽3~6份、水解二型胶原蛋白肽粉2~8份、唾液酸6~12份、酵母抽提物6~8份、γ-氨基丁酸8~13份,雨生红球藻10~16份、血橙果粉7~12份、橄榄果粉3~6份、针叶樱桃果粉3~6份、鲑鱼蛋白粉2~5份、柠檬酸0.08~0.14份、维生素C3~8份、食用香精0.05~0.1份、山梨酸钾0.05~0.1份。
2.一种根据权利要求1所述的唾液酸复合果蔬汁饮品的制备方法,其特征在于,具体包括以下步骤:
(1)、将海洋鱼低聚肽粉、胶原蛋白肽、鲣鱼弹性蛋白肽、水解二型胶原蛋白肽粉和酵母抽提物混合均匀;
(2)、然后将低聚果糖、唾液酸加入第一份纯净水中溶解,搅拌均匀;
(3)、将步骤(1)中的混合物加入步骤(2)的溶液中,剪切乳化,均质,得到第一份分散液;
(4)、将γ-氨基丁酸、雨生红球藻、鲑鱼蛋白粉和维生素C加入到第二份纯净水中,剪切乳化,均质,得到第二份分散液;
(5)、将苹果浓缩汁、梨浓缩汁、葡萄籽提取物、血橙果粉、橄榄果粉、针叶樱桃果粉和食用香精加入到第三份纯净水,均质,得到第三份分散液;
(6)、将上述第一份分散液、第二份分散液和第三份分散液混合,剪切乳化,均质;
(7)、然后加入柠檬酸、食用香精和山梨酸钾,继续剪切乳化,均质即得唾液酸复合果蔬汁饮品。
3.根据权利要求2所述的一种唾液酸复合果蔬汁饮品的制备方法,其特征在于,所述步骤(3)中第一份分散液剪切乳化时温度维持在45℃~48℃之间。
4.根据权利要求2所述的一种唾液酸复合果蔬汁饮品的制备方法,其特征在于,所述步骤(4)中第二份分散液剪切乳化时温度维持在38℃~40℃之间。
5.根据权利要求2所述的一种唾液酸复合果蔬汁饮品的制备方法,其特征在于,所述步骤(5)中第三份分散液剪切乳化时温度维持在38℃~40℃之间。
6.根据权利要求2所述的一种唾液酸复合果蔬汁饮品的制备方法,其特征在于,所述第一份纯净水、第二份纯净水和第三份纯净水质量比为:1:1:1。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110571475.6A CN113142437A (zh) | 2021-05-25 | 2021-05-25 | 一种唾液酸复合果蔬汁饮品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110571475.6A CN113142437A (zh) | 2021-05-25 | 2021-05-25 | 一种唾液酸复合果蔬汁饮品及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113142437A true CN113142437A (zh) | 2021-07-23 |
Family
ID=76877338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110571475.6A Pending CN113142437A (zh) | 2021-05-25 | 2021-05-25 | 一种唾液酸复合果蔬汁饮品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113142437A (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113475654A (zh) * | 2021-08-05 | 2021-10-08 | 江西汪氏蜜蜂园有限公司 | 一种风味胶原蛋白饮品制备工艺 |
CN113558162A (zh) * | 2021-07-30 | 2021-10-29 | 中科鸿基生物科技有限公司 | 一种唾液酸复合植物酵素饮品 |
CN114304447A (zh) * | 2022-01-14 | 2022-04-12 | 北京极暖网络科技有限公司 | 一种促排燃脂阻脂裹油并且服用能产生暖感的液体饮料 |
CN115869205A (zh) * | 2021-09-27 | 2023-03-31 | 嘉必优生物技术(武汉)股份有限公司 | 抗非酶糖基化组合物及其应用、非酶糖基化抑制剂 |
CN116491615A (zh) * | 2023-05-17 | 2023-07-28 | 哈尔滨三联药业股份有限公司 | 美藤果油胶原蛋白肽饮料组合物及其制备方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009261370A (ja) * | 2008-04-30 | 2009-11-12 | Uha Mikakuto Co Ltd | コラーゲンペプチド含有飲料及びその製造方法 |
CN106723000A (zh) * | 2017-01-12 | 2017-05-31 | 南京圣诺生物科技实业有限公司 | 美容养颜的组合物及美容养颜产品 |
CN108354096A (zh) * | 2018-02-06 | 2018-08-03 | 北京姿美堂生物技术有限公司 | 一种抗皱保湿、改善皮肤弹性的胶原蛋白复合饮品 |
CN109744446A (zh) * | 2019-02-19 | 2019-05-14 | 杭州海王生物工程有限公司 | 一种含n-乙酰神经氨酸的乳清蛋白类固体饮料及其制备方法 |
CN111513224A (zh) * | 2020-04-26 | 2020-08-11 | 湖南益优健康产业有限公司 | 一种适用于耐力运动的固体饮料 |
CN111990558A (zh) * | 2020-08-11 | 2020-11-27 | 成都蜜儿堂职业技能培训学校有限公司 | 一种吸收效果好的美白抗氧化复合果饮及其制备方法 |
US20210030849A1 (en) * | 2018-02-09 | 2021-02-04 | Suntory Holdings Limited | Liquid composition for oral use containing collagen peptide, and method for improving flavor of liquid composition for oral use including collagen peptide |
-
2021
- 2021-05-25 CN CN202110571475.6A patent/CN113142437A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009261370A (ja) * | 2008-04-30 | 2009-11-12 | Uha Mikakuto Co Ltd | コラーゲンペプチド含有飲料及びその製造方法 |
CN106723000A (zh) * | 2017-01-12 | 2017-05-31 | 南京圣诺生物科技实业有限公司 | 美容养颜的组合物及美容养颜产品 |
CN108354096A (zh) * | 2018-02-06 | 2018-08-03 | 北京姿美堂生物技术有限公司 | 一种抗皱保湿、改善皮肤弹性的胶原蛋白复合饮品 |
US20210030849A1 (en) * | 2018-02-09 | 2021-02-04 | Suntory Holdings Limited | Liquid composition for oral use containing collagen peptide, and method for improving flavor of liquid composition for oral use including collagen peptide |
CN109744446A (zh) * | 2019-02-19 | 2019-05-14 | 杭州海王生物工程有限公司 | 一种含n-乙酰神经氨酸的乳清蛋白类固体饮料及其制备方法 |
CN111513224A (zh) * | 2020-04-26 | 2020-08-11 | 湖南益优健康产业有限公司 | 一种适用于耐力运动的固体饮料 |
CN111990558A (zh) * | 2020-08-11 | 2020-11-27 | 成都蜜儿堂职业技能培训学校有限公司 | 一种吸收效果好的美白抗氧化复合果饮及其制备方法 |
Non-Patent Citations (1)
Title |
---|
杨晓等: "低聚肽和VC复合固体饮料的抗氧化性研究", 《食品研究与开发》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113558162A (zh) * | 2021-07-30 | 2021-10-29 | 中科鸿基生物科技有限公司 | 一种唾液酸复合植物酵素饮品 |
CN113475654A (zh) * | 2021-08-05 | 2021-10-08 | 江西汪氏蜜蜂园有限公司 | 一种风味胶原蛋白饮品制备工艺 |
CN115869205A (zh) * | 2021-09-27 | 2023-03-31 | 嘉必优生物技术(武汉)股份有限公司 | 抗非酶糖基化组合物及其应用、非酶糖基化抑制剂 |
CN114304447A (zh) * | 2022-01-14 | 2022-04-12 | 北京极暖网络科技有限公司 | 一种促排燃脂阻脂裹油并且服用能产生暖感的液体饮料 |
CN116491615A (zh) * | 2023-05-17 | 2023-07-28 | 哈尔滨三联药业股份有限公司 | 美藤果油胶原蛋白肽饮料组合物及其制备方法 |
CN116491615B (zh) * | 2023-05-17 | 2023-09-12 | 哈尔滨三联药业股份有限公司 | 美藤果油胶原蛋白肽饮料组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113142437A (zh) | 一种唾液酸复合果蔬汁饮品及其制备方法 | |
CN103598334A (zh) | 一种果蔬酸奶饮料及制作方法 | |
US20200288752A1 (en) | Ferment collagen drink and the method of preparing the same | |
CN102146333A (zh) | 一种蓝莓、枸杞汽酒及其生产方法 | |
CN104642546A (zh) | 一种酸奶及其制备方法 | |
CN103976023A (zh) | 一种黄秋葵酸乳饮料及其制备方法 | |
CN113907224A (zh) | 一种透明质酸钠青春饮的组成配方 | |
CN111480850A (zh) | 一种雨生红球藻加胶原蛋白饮品 | |
CN107232471A (zh) | 一种营养固体饮料 | |
CN113615783A (zh) | 一种牦牛胶原蛋白肽运动饮料 | |
CN112753768A (zh) | 一种植物双蛋白发酵风味酸奶及制备方法 | |
CN112704210A (zh) | 一种利用西红柿制备的果蔬酸汤汁及其制备方法和应用 | |
CN110547447A (zh) | 一种蜂王浆胶原蛋白水果酵素及其制作方法 | |
CN106306937A (zh) | 浓缩发酵桑葚汁及其制备方法 | |
CN108485868A (zh) | 一种奶酒的生产方法 | |
CN102078016A (zh) | 一种灵芝、山药饮品及其制备方法 | |
CN106922818A (zh) | 一种鳄梨果汁酸奶饮料及其制备方法 | |
CN103636786A (zh) | 一种乌黑亮发的酸奶及制备方法 | |
CN109497367A (zh) | 一种蛋清低聚肽果汁饮料及其制备方法 | |
CN114947085A (zh) | 一种含螺旋藻与藻蓝蛋白的生椰拿铁味多功能营养果冻及其制备方法 | |
CN101416660A (zh) | 一种海参酸牛奶及其制备方法 | |
CN109043259A (zh) | 一种酵素l-阿拉伯糖水苏糖复合饮料浓浆 | |
CN102232589A (zh) | 一种草莓果肉果汁醋酸饮料及其制备方法 | |
CN114304624A (zh) | 含有蛋壳膜粉末和水解蛋壳膜成分的饮料 | |
CN105532892A (zh) | 一种人参木瓜酵素奶片及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210723 |